Instalment payments could be used across gene therapy space, Spark CEO says

16 May 2019 - In a fireside chat at the recently concluded Veeva Summit in Philadelphia, Jeff Marrazzo said payment over ...

Read more →

A $1 discount on prescription medicines is under threat

16 May 2019 - Australians are likely to pay more for prescription medicines no matter who wins the election on ...

Read more →

Many hospitals charge double or even triple what Medicare would pay

9 May 2019 - The Parkview Health System in Indiana had among the highest overall hospital prices compared to Medicare rates, ...

Read more →

Cancer specialists ‘won’t increase’ fees under Labor plan

9 May 2019 - Australia’s cancer doctors have rejected Scott Morrison’s claims they will charge patients higher fees under Labor’s ...

Read more →

Health funds want to raise a tax penalty to force you to buy their products

4 May 2019 - A $900 plus tax penalty to force the rich to buy private health insurance is now ...

Read more →

Trump drug rebate plan won't see lower list prices, CBO says

3 May 2019 - Plan would raise federal spending by $177 billion, agency says. ...

Read more →

At a lively drug pricing debate, experts suggest killing off copays

25 April 2019 - It was billed as a debate on sky-high prescription drug prices — but once again, middlemen ...

Read more →

Ending drug rebates will not reduce drug prices

22 April 2019 - There are many reasons why drug prices are so high, beginning with the fact that it ...

Read more →

Plan to end drug rebates adds protections for insurers

5 April 2019 - Administration’s move to backstop losses could prevent premiums from rising significantly. ...

Read more →

A new safe harbour — turning drug rebates into discounts in Medicare Part D

3 April 2019 - A proposal to require drug companies to pass discounts directly to Medicare patients at the point of ...

Read more →

Cigna’s Express Scripts PBM to cap insulin costs amid drug price scrutiny

3 April 2019 - Cigna and its Express Scripts pharmacy benefit management unit Wednesday said they are rolling out a ...

Read more →

Regulatory information – 1.7% increase of fees from 1 April 2019

1 April 2019 - General, non-pharmacovigilance fees payable to EMA by applicants and marketing-authorisation holders are increasing by 1.7% on ...

Read more →

Coalition attacks Trump plan to end drug rebates, calling it a ‘big pharma bailout’

28 March 2019 - A coalition that includes pharmacy middlemen and insurers has launched a six-figure ad campaign attacking a ...

Read more →

Charging for technology appraisals and highly specialised technologies

27 March 2019 - From 1 April 2019 NICE will charge for technology appraisal and highly specialised technologies assessments. ...

Read more →

Kentucky launches probe into drug overcharges by pharmacy benefit managers

22 March 2019 - Kentucky Attorney General Andy Beshear said on Thursday he had launched an investigation into allegations that ...

Read more →